Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 502, pseudogene (RNU6-502P)
- Target
- RNU6-502P
- Molecular classification
- Other (Pseudogene), Small nuclear RNA pseudogene
01
Overview
RNU6-502P (RNA, U6 small nuclear 502, pseudogene) is a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family, specifically representing a nonfunctional copy of the canonical U6 snRNA gene. U6 snRNA is a critical non-coding RNA component of the spliceosome, essential for pre-mRNA splicing[1][3]. However, as a pseudogene, RNU6-502P does not produce a functional RNA product or protein, and is not known to play any direct biological or therapeutic role[4][7]. Like other pseudogenes, it may arise from duplication or retrotransposition events. There is no evidence linking this pseudogene to disease mechanisms, biomarker activity, or drug interaction[2][7]. The gene is cataloged in multiple genomic databases with aliases corresponding to its identifiers[7][4].
- Other names
- RNU6-502PRNA, U6 small nuclear 502, pseudogeneENSG00000199289 (Ensembl)106481899 (NCBI Gene)HGNC:47465GC06M026521 (GeneCards)
02
Mechanism of action
None
03
Biological functions
None (pseudogenes do not encode functional products)U6 snRNA parent involved in pre-mRNA splicing as part of the spliceosome, but RNU6-502P itself has no known function
04
Disease associations
None known (no evidence of involvement in disease)Pseudogenes in general may sometimes be involved in regulatory functions, but no direct evidence for RNU6-502P
Beyond the preview
Go deeper on RNA, U6 small nuclear 502, pseudogene (RNU6-502P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 502, pseudogene (RNU6-502P).